Bioventus LLC
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Bioventus LLC - overview
Established
2012
Location
Durham, NC, US
Primary Industry
Medical Devices & Equipment
About
Based in North Carolina, US, and founded in 2012, Bioventus LLC is a privately held company operating as the biologics division of Smith & Nephew. It operates as a provider of bone stimulation devices and osteoarthritis joint fluid therapies. As of 2020, Robert Claypoole operates as the CEO of Bioventus LLC. In November 2020, Bioventus received authorization to proceed with MOTYS clinical trials.
Bioventus' other offices are located in Tennessee and The Netherlands. In February 2021, the company listed on the Nasdaq Global Select Market with the ticker BVS. The company works with its researchers to provide products that include the EXOGEN Ultrasound Bone Healing System, a system where painless ultrasound waves activate the cells near the site of the break to stimulate the body’s natural healing process. It also develops non-surgical joint pain injection therapies that work with the body's biological processes to provide a natural lubricant to the joint.
Its researchers also focus on the PTP-001 (commercial trade name MOTYS™), a placental tissue particulate, for the treatment of osteoarthritis of the knee. Another product of the company is Bioventus Surgical, a portfolio of surgical biologics that offers a variety of bone graft solutions.
Current Investors
Alta Partners, Ampersand, Essex Woodlands
Primary Industry
Medical Devices & Equipment
Sub Industries
Chiropractic, Orthopedic & Physical Therapy, Diagnostic Equipment, Biomaterials
Website
www.bioventus.com/
Verticals
Manufacturing
Company Stage
Mature
Total Amount Raised
Subscriber access only
Bioventus LLC - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Corporate Carve Out | Completed | Bioness Inc.'s Advanced Rehabilitation business | - | ||||||||
| Add-on, Trade Sale | Completed | Bioness Inc. | - | ||||||||
| IPO | Completed | Bioventus LLC | - | ||||||||
| Private Debt | Completed | Bioventus LLC | - | ||||||||
| Spin-Off | Completed | Bioventus LLC | - |
Displaying 1 - 5 of 5
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.